Innovative drug concept stocks rose in early trading, with Beigene up over 6%
Innovative drug concept stocks rose at the beginning of the trading session, with RemeGen up over 14%, ApicHope and Jincheng Pharmaceutical up over 7%, Junshi Biosciences and Beigene up over 6%, and Baillie Gifford and Kangchen Pharmaceutical following suit
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments